Literature DB >> 31391720

Measured Versus Calculated Small Dense LDL-Cholesterol and Cardiometabolic Traits in a South African Population.

M Masoud1, A P Kengne2,3, R T Erasmus4, G M Hon1, M Macharia4, T E Matsha1.   

Abstract

Small-dense low density lipoprotein (sdLDL) is increasingly viewed as a marker for evaluating atherogenic risk, however its clinical uptake is hampered by the cumbersomeness of available methods. Consequently, a number of alternative methods for the estimation of sdLDL have been developed and none have been tested in a population from Africa. We evaluated an equation to estimate sdLDL-C from classic lipid parameters in South Africans. This is a cross-sectional study involving 1550 participants in which direct measurement of sdLDL in 237 participants was performed using a homogeneous enzymatic assay. Their mean age (standard deviation, SD) was 54.2 (14.7) years. 156 (65.8%) were normotolerant, 29 (12.2%) prediabetes, 17 (7.2%) screen detected diabetes and 35 (14.8%) known diabetes. Measured sdLDL values ranged from 0.17 to 3.39 versus-1.85 to 2.52 mmol/L calculated sdLDL. There was a significant positive correlation between the two measurements with a Pearson correlation coefficient of 0.659 (95%CI: 0.581-0.726). In a regression model, the adjusted R2 was 0.440 after adding age, 0.441 after further adding gender, then 0.443 with dysglycemia and lastly 0.447 upon adding body mass index. With the exception of HDL-cholesterol levels that decreased across increasing quintiles of calculated sdLDL, our data showed significant correlations between sdLDL and cardiometabolic risk factors, all p values < 0.0001. In conclusion, this study has shown that calculated sdLDL can be efficiently used to approximate population levels of sdLDL; however the modest correlation indicate that at the individual level, it will poorly approximate true sdLDL levels, with possible implications for risk stratification.

Entities:  

Keywords:  Africa; Diabetes; Lipids; Metabolic syndrome; Small-dense low density lipoprotein

Year:  2018        PMID: 31391720      PMCID: PMC6660522          DOI: 10.1007/s12291-018-0748-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

1.  LDL particle size by gradient-gel electrophoresis cannot be estimated by LDL-cholesterol/apolipoprotein B ratios.

Authors:  D Furuya; A Yagihashi; S Nasu; T Endoh; T Nakamura; R Kaneko; C Kamagata; D Kobayashi; N Watanabe
Journal:  Clin Chem       Date:  2000-08       Impact factor: 8.327

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

Authors:  J de Graaf; H L Hak-Lemmers; M P Hectors; P N Demacker; J C Hendriks; A F Stalenhoef
Journal:  Arterioscler Thromb       Date:  1991 Mar-Apr

4.  LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.

Authors:  A M Wägner; O Jorba; M Rigla; E Alonso; J Ordóñez-Llanos; A Pérez
Journal:  Acta Diabetol       Date:  2002-12       Impact factor: 4.280

5.  Development of a homogeneous assay for measurement of small dense LDL cholesterol.

Authors:  Yasuki Ito; Miki Fujimura; Motoko Ohta; Tsutomu Hirano
Journal:  Clin Chem       Date:  2010-11-04       Impact factor: 8.327

6.  1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization.

Authors:  J Chalmers; S MacMahon; G Mancia; J Whitworth; L Beilin; L Hansson; B Neal; A Rodgers; C Ni Mhurchu; T Clark
Journal:  Clin Exp Hypertens       Date:  1999 Jul-Aug       Impact factor: 1.749

7.  Estimation of plasma small dense LDL cholesterol from classic lipid measures.

Authors:  Pornpen Srisawasdi; Sirirat Chaloeysup; Yaovalak Teerajetgul; Anothai Pocathikorn; Chonlaphat Sukasem; Somlak Vanavanan; Martin H Kroll
Journal:  Am J Clin Pathol       Date:  2011-07       Impact factor: 2.493

Review 8.  Small dense LDL: An emerging risk factor for cardiovascular disease.

Authors:  Satoshi Hirayama; Takashi Miida
Journal:  Clin Chim Acta       Date:  2012-09-16       Impact factor: 3.786

9.  Observational study of lipid profile and LDL particle size in patients with metabolic syndrome.

Authors:  Natalia Sancho-Rodríguez; Francisco V Avilés-Plaza; Esteban Granero-Fernández; Antonio M Hernández-Martínez; María Dolores Albaladejo-Otón; Pedro Martínez-Mernández; Soledad Parra-Pallarés
Journal:  Lipids Health Dis       Date:  2011-09-21       Impact factor: 3.876

10.  The 30-year cardiovascular risk profile of South Africans with diagnosed diabetes, undiagnosed diabetes, pre-diabetes or normoglycaemia: the Bellville, South Africa pilot study.

Authors:  T E Matsha; M S Hassan; M Kidd; R T Erasmus
Journal:  Cardiovasc J Afr       Date:  2012-02       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.